semaglutide fda approval date U.S. | The FDA has approved a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight BREAKING: The FDA has approved

(11) Supporting immune function and helping to control inflammation

Diabetes 62, 12891296

Research published in Biogerontology confirmed that Epithalon treatment of human somatic cells induces expression of the telomerase catalytic subunit (hTERT), enzymatic activity of telomerase, and significant telomere elongation

GLP-1s are a bottom-up approach, using gut hormones to create a natural feeling of fullness and metabolic balance

But the newer research shows they do something rheumatology cares about a lot: they lower inflammation and part of that effect appears to be independent of weight loss

Injectable administration provides immediate bioavailability with peak concentrations achieved in minutes rather than hours